硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 MAP3K5 抗体对
试剂盒

抗人 MAP3K5 抗体对

01AB00897

Mitogen-activated protein kinase kinase kinase 5 (MAP3K5), also termed apoptosis signal-regulating kinase 1 (ASK1), is a serine/threonine kinase that activates the JNK and p38 MAPK pathways, mediating cellular responses to oxidative stress, cytokines, and endoplasmic reticulum stress. Structurally, MAP3K5 contains an N-terminal thioredoxin-binding domain, a central kinase domain, and a C-terminal coiled-coil domain, enabling interactions with regulators like thioredoxin (inhibiting its activity under redox balance) and TRAF proteins. Post-translational modifications, such as phosphorylation (e.g., at Thr845) and ubiquitination, tightly regulate its function in apoptosis, inflammation, and differentiation. Dysregulation of MAP3K5 is linked to multiple diseases. Overactivation due to mutations or oxidative stress is associated with cardiovascular disorders, including dilated cardiomyopathy, and diabetic nephropathy via excessive apoptosis. Conversely, impaired MAP3K5 activity may promote cancer by reducing stress-induced cell death. Its role in neuroinflammation also implicates it in neurodegenerative diseases like Alzheimer’s.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
MAP3K5
基因别名
ASK1; MAPKKK5; MEKK5
蛋白别名
mitogen-activated protein kinase kinase kinase 5; MAP3K5
UniProt
Q99683
物种
Human

产品详情

靶点名称
MAP3K5
蛋白名称
mitogen-activated protein kinase kinase kinase 5
蛋白别名
Mitogen-activated protein kinase kinase kinase 5; Apoptosis signal-regulating kinase 1; ASK-1; MAPK/ERK kinase kinase 5; MEK kinase 5; MEKK 5
靶点基因名
MAP3K5
基因别名
ASK1; MAPKKK5; MEKK5
UniProt
Q99683
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Mitogen-activated protein kinase kinase kinase 5 (MAP3K5), also termed apoptosis signal-regulating kinase 1 (ASK1), is a serine/threonine kinase that activates the JNK and p38 MAPK pathways, mediating cellular responses to oxidative stress, cytokines, and endoplasmic reticulum stress. Structurally, MAP3K5 contains an N-terminal thioredoxin-binding domain, a central kinase domain, and a C-terminal coiled-coil domain, enabling interactions with regulators like thioredoxin (inhibiting its activity under redox balance) and TRAF proteins. Post-translational modifications, such as phosphorylation (e.g., at Thr845) and ubiquitination, tightly regulate its function in apoptosis, inflammation, and differentiation. Dysregulation of MAP3K5 is linked to multiple diseases. Overactivation due to mutations or oxidative stress is associated with cardiovascular disorders, including dilated cardiomyopathy, and diabetic nephropathy via excessive apoptosis. Conversely, impaired MAP3K5 activity may promote cancer by reducing stress-induced cell death. Its role in neuroinflammation also implicates it in neurodegenerative diseases like Alzheimer’s.